In some cases of MPM, the mutation was associated with the increase of the neo-antigen carcinoma and the inhibition of PD-1 (44 45).
In alcuni casi di MPM il carico mutazionale era associato all’incremento del carico di neo-antigeni e dell’inibizione di PD-1 (44 45).